Endogenous tumor necrosis factor inhibits the cytotoxicity of exogenous tumor necrosis factor and adriamycin in pancreatic carcinoma cells

Pancreatic carcinoma is one of the most devastating neoplasms with regard to its resistance to conventional therapy. In a previous report, we found that endogenous tumor necrosis factor (enTNF) exerts an intracellular protective effect against exogenous TNF- and Adriamycin (ADM)-induced cytotoxicity...

Full description

Saved in:
Bibliographic Details
Published inPancreas Vol. 13; no. 4; p. 395
Main Authors Watanabe, N, Tsuji, N, Tsuji, Y, Sasaki, H, Okamoto, T, Akiyama, S, Kobayashi, D, Sato, T, Yamauchi, N, Niitsu, Y
Format Journal Article
LanguageEnglish
Published United States 01.11.1996
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Pancreatic carcinoma is one of the most devastating neoplasms with regard to its resistance to conventional therapy. In a previous report, we found that endogenous tumor necrosis factor (enTNF) exerts an intracellular protective effect against exogenous TNF- and Adriamycin (ADM)-induced cytotoxicity by scavenging oxygen free radicals (OFR) with induced manganous superoxide dismutase (MnSOD). We also know that glutathione S-transferase pi (GST-pi) and glutathione (GSH) also scavenge OFR. It remains unclear to what extent enTNF and MnSOD induced by enTNF regulate the sensitivity to ADM and exogenous TNF among different carcinoma cells. In this study, we examined the relationship between ADM and exogenous TNF sensitivity and en-TNF expression and MnSOD activity in four pancreatic carcinoma lines. We determined whether ADM and exogenous TNF sensitivity could be predicted by measuring enTNF expression and MnSOD activity in the carcinoma cells. The sensitivity to TNF and ADM varied with the cell lines, and TNF sensitivity correlated well with Adriamycin sensitivity. Moreover, enTNF expression and Mn-SOD activity correlated positively with resistance to ADM and exogenous TNF. When MIAPaCa-2 cells, which had the lowest enTNF expression and the highest sensitivity to exogenous TNF and ADM, were transfected with the nonsecretory-type human TNF gene (pTNF delta pro) to increase enTNF synthesis, their intracellular MnSOD activity and exogenous TNF and ADM resistance were increased. These findings suggest that MnSOD plays a critical role in scavenging OFR induced by ADM and exogenous TNF. enTNF is the most important factor that regulates the production of MnSOD. Therefore, it is plausible that inhibition of enTNF expression or MnSOD activity in pancreatic carcinoma would improve the efficacy of therapies for pancreatic carcinoma.
AbstractList Pancreatic carcinoma is one of the most devastating neoplasms with regard to its resistance to conventional therapy. In a previous report, we found that endogenous tumor necrosis factor (enTNF) exerts an intracellular protective effect against exogenous TNF- and Adriamycin (ADM)-induced cytotoxicity by scavenging oxygen free radicals (OFR) with induced manganous superoxide dismutase (MnSOD). We also know that glutathione S-transferase pi (GST-pi) and glutathione (GSH) also scavenge OFR. It remains unclear to what extent enTNF and MnSOD induced by enTNF regulate the sensitivity to ADM and exogenous TNF among different carcinoma cells. In this study, we examined the relationship between ADM and exogenous TNF sensitivity and en-TNF expression and MnSOD activity in four pancreatic carcinoma lines. We determined whether ADM and exogenous TNF sensitivity could be predicted by measuring enTNF expression and MnSOD activity in the carcinoma cells. The sensitivity to TNF and ADM varied with the cell lines, and TNF sensitivity correlated well with Adriamycin sensitivity. Moreover, enTNF expression and Mn-SOD activity correlated positively with resistance to ADM and exogenous TNF. When MIAPaCa-2 cells, which had the lowest enTNF expression and the highest sensitivity to exogenous TNF and ADM, were transfected with the nonsecretory-type human TNF gene (pTNF delta pro) to increase enTNF synthesis, their intracellular MnSOD activity and exogenous TNF and ADM resistance were increased. These findings suggest that MnSOD plays a critical role in scavenging OFR induced by ADM and exogenous TNF. enTNF is the most important factor that regulates the production of MnSOD. Therefore, it is plausible that inhibition of enTNF expression or MnSOD activity in pancreatic carcinoma would improve the efficacy of therapies for pancreatic carcinoma.
Author Yamauchi, N
Sasaki, H
Okamoto, T
Akiyama, S
Watanabe, N
Kobayashi, D
Sato, T
Tsuji, N
Tsuji, Y
Niitsu, Y
Author_xml – sequence: 1
  givenname: N
  surname: Watanabe
  fullname: Watanabe, N
  organization: Fourth Department of Internal Medicine, Sapporo Medical University, School of Medicine, Japan
– sequence: 2
  givenname: N
  surname: Tsuji
  fullname: Tsuji, N
– sequence: 3
  givenname: Y
  surname: Tsuji
  fullname: Tsuji, Y
– sequence: 4
  givenname: H
  surname: Sasaki
  fullname: Sasaki, H
– sequence: 5
  givenname: T
  surname: Okamoto
  fullname: Okamoto, T
– sequence: 6
  givenname: S
  surname: Akiyama
  fullname: Akiyama, S
– sequence: 7
  givenname: D
  surname: Kobayashi
  fullname: Kobayashi, D
– sequence: 8
  givenname: T
  surname: Sato
  fullname: Sato, T
– sequence: 9
  givenname: N
  surname: Yamauchi
  fullname: Yamauchi, N
– sequence: 10
  givenname: Y
  surname: Niitsu
  fullname: Niitsu, Y
BackLink https://www.ncbi.nlm.nih.gov/pubmed/8899800$$D View this record in MEDLINE/PubMed
BookMark eNp9kE1qwzAQhbVISZO0RyjoAm4l2_qZZQnpDwS6addBHsmNSiwFS4H4Cj11VZp1ZzO895gP5i3JLMTgCKGc3XMG6oGVkVLJigNIzouqfi2YkQXTWlQNV-qaLFP6YoyrRsCczLUG0IwtyPcm2PjpQjwlmk9DHGlwOMbkE-0N5qJ92PvO5xLvHcUpxxzPHn2eaOypO_9_bIKlxo7eDBP6UFj0aAKOzmSPFM1YzDgYiu5wSDfkqjeH5G4ve0U-njbv65dq-_b8un7cVtgylSsFqLnuQSJrLG_AYg8NZ5yJpnzdMu6gVTV2iCBqKa10hqMTIABa0emuXpG7P-7x1A3O7o6jH8w47S6d1D9a7WhZ
CitedBy_id crossref_primary_10_1053_gast_2001_23627
crossref_primary_10_1081_DMR_200033488
crossref_primary_10_1371_journal_pone_0077126
crossref_primary_10_1111_j_1349_7006_2001_tb01189_x
crossref_primary_10_3109_02656739809018235
crossref_primary_10_1097_00006676_200203000_00007
crossref_primary_10_1054_bjoc_2001_1954
crossref_primary_10_1016_j_tox_2008_02_018
crossref_primary_10_1074_jbc_M208665200
crossref_primary_10_3109_10428199909083376
crossref_primary_10_1097_mpa_0b013e31814dadf5
crossref_primary_10_1158_0008_5472_CAN_07_5704
crossref_primary_10_1111_j_1349_7006_2000_tb00906_x
crossref_primary_10_1002__SICI_1097_0215_19980518_76_4_552__AID_IJC18_3_0_CO_2_9
crossref_primary_10_1248_bpb_b13_00121
crossref_primary_10_1593_neo_06646
crossref_primary_10_1073_pnas_0611660104
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1097/00006676-199611000-00009
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 8899800
Genre Journal Article
GroupedDBID ---
.-D
.55
.GJ
.XZ
.Z2
0R~
123
4Q1
4Q2
4Q3
53G
5RE
5VS
8L-
AAAAV
AAHPQ
AAIQE
AAJCS
AAMTA
AARTV
AASCR
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABVCZ
ABXVJ
ABZAD
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACWDW
ACWRI
ACXJB
ACXNZ
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFDTB
AFEXH
AFUWQ
AHQNM
AHRYX
AHVBC
AINUH
AJIOK
AJNWD
AJNYG
AJZMW
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AWKKM
BQLVK
BS7
C45
CGR
CS3
CUY
CVF
DIWNM
DU5
DUNZO
E.X
EBS
ECM
EEVPB
EIF
EJD
EX3
F2K
F2L
F5P
FCALG
FL-
GNXGY
GQDEL
H0~
HLJTE
HZ~
IKREB
IN~
JF9
JG8
JK3
JK8
K8S
KD2
KMI
L-C
N9A
NPM
N~M
O9-
OAG
OAH
OCUKA
ODA
ODMTH
OHYEH
OJAPA
OL1
OLG
OLV
OLW
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
R58
RLZ
S4R
S4S
T8P
TEORI
TSPGW
V2I
VVN
W3M
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
ZFV
ZXP
ZZMQN
ID FETCH-LOGICAL-c407t-79c818f96c03d139dcf93101053000401e9472cbcc95266d6ea1ce5959945b8b2
ISSN 0885-3177
IngestDate Sat Sep 28 08:39:34 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c407t-79c818f96c03d139dcf93101053000401e9472cbcc95266d6ea1ce5959945b8b2
PMID 8899800
ParticipantIDs pubmed_primary_8899800
PublicationCentury 1900
PublicationDate 1996-11-01
PublicationDateYYYYMMDD 1996-11-01
PublicationDate_xml – month: 11
  year: 1996
  text: 1996-11-01
  day: 01
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Pancreas
PublicationTitleAlternate Pancreas
PublicationYear 1996
SSID ssj0017359
Score 1.6089362
Snippet Pancreatic carcinoma is one of the most devastating neoplasms with regard to its resistance to conventional therapy. In a previous report, we found that...
SourceID pubmed
SourceType Index Database
StartPage 395
SubjectTerms Doxorubicin - therapeutic use
Drug Resistance, Neoplasm
Gene Expression
Humans
Pancreatic Neoplasms - drug therapy
Pancreatic Neoplasms - enzymology
Superoxide Dismutase - metabolism
Transfection
Tumor Cells, Cultured
Tumor Necrosis Factor-alpha - genetics
Tumor Necrosis Factor-alpha - pharmacology
Tumor Necrosis Factor-alpha - therapeutic use
Title Endogenous tumor necrosis factor inhibits the cytotoxicity of exogenous tumor necrosis factor and adriamycin in pancreatic carcinoma cells
URI https://www.ncbi.nlm.nih.gov/pubmed/8899800
Volume 13
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEBWbhpRcStM29Bsdcltc7Ei2rGMpKaGQEMiG5hasL-LC2qHrhaQ_oZf-5c5IstdNNqHtxSzSWqw9b0dvpNEbQvY4Fw5mGpswk5cQoFiTVA6iFJ2x0jCpjZB4GvnouDg841_O8_PJ5Ncoa2nZqQ_6x9pzJf9jVWgDu-Ip2X-w7DAoNMBnsC9cwcJw_SsbHzSmjSKr3XLefp82Fme9ehHL6Ezr5rJWuDWA9FLfdG3XXtc6ZmHY64dv9jKuBh5jfqNrnxAJniOQTI2K1tDYzqspLv0vxhz3JHxrIOtfKyCglbJ_bPzMFstv9fqWgVyfVotqVFU7LE74fOZsWJzofRhutMdKLb3DZSNg8ZH3ZKHe5h2vHtSC_dRaiAJzYwpUuvNH4r24Qjcy9tXcW7vEQNKLoD7ceUttO_ZskA1RosM8xsWfuCklmK-9NzxTTAzrNUDX_bZtshVHvBW2ePoye0qexLiDfgwg2iET2zwjj49iZsVz8nOFJerhQHs40AAH2mOJApboGEu0dXTA0j03A5boCkswFl1hiQ5Yoh5LL8jZ54PZp8Mk1ulINE9FlwipgfY5WeiUGYgojHYSogZg7gxDhjSzkot9rbSWOfBBU9gqw9N_uZQ8V6Xa3yWPmraxLwmtgF1yzGxWmeKpK8rUoSCcFs6w3OjsFdkNb_HiKoixXMTX-_q-jjdkewXMt2TTwX_fvgMi2an33ry_AdRec-A
link.rule.ids 786
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Endogenous+tumor+necrosis+factor+inhibits+the+cytotoxicity+of+exogenous+tumor+necrosis+factor+and+adriamycin+in+pancreatic+carcinoma+cells&rft.jtitle=Pancreas&rft.au=Watanabe%2C+N&rft.au=Tsuji%2C+N&rft.au=Tsuji%2C+Y&rft.au=Sasaki%2C+H&rft.date=1996-11-01&rft.issn=0885-3177&rft.volume=13&rft.issue=4&rft.spage=395&rft_id=info:doi/10.1097%2F00006676-199611000-00009&rft_id=info%3Apmid%2F8899800&rft_id=info%3Apmid%2F8899800&rft.externalDocID=8899800
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-3177&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-3177&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-3177&client=summon